- Home
- INAB
INAB
IN8bio Inc.
as of 12-24-2025 12:35pm EST
$1.98
+$0.23
+13.14%
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 10.6M | IPO Year: | 2021 |
| Target Price: | $108.00 | AVG Volume (30 days): | 653.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.17 - $12.53 | Next Earning Date: | 11-06-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered INAB Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 70.86%
70.86%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest IN8bio Inc. News
INAB Breaking Stock News: Dive into INAB Ticker-Specific Updates for Smart Investing
USA TODAY
Santa tracker 2025: Follow his Christmas Eve trip using NORAD, Google
➖
AI Sentiment
Neutral
5/10
ACCESS Newswire
2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement
📊
AI Sentiment
Positive
7/10
PR Newswire
Consult PR Shares Updates on AI Pay-Per-Click Challenges With Niche Keywords Categories
📊
AI Sentiment
Positive
6/10
Compare INAB vs Leading Stocks
See how INAB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "INAB IN8bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.